nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Lamivudine—hepatitis B	0.286	1	CrCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Telbivudine—hepatitis B	0.148	0.392	CiPCiCtD
Emtricitabine—DCK—Lamivudine—hepatitis B	0.12	1	CbGbCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Lamivudine—hepatitis B	0.112	0.297	CiPCiCtD
Emtricitabine—Nucleoside Analog—Telbivudine—hepatitis B	0.0665	0.177	CiPCiCtD
Emtricitabine—Zalcitabine—Lamivudine—hepatitis B	0.0536	0.306	CrCrCtD
Emtricitabine—Nucleoside Analog—Lamivudine—hepatitis B	0.0504	0.134	CiPCiCtD
Emtricitabine—Floxuridine—Telbivudine—hepatitis B	0.0423	0.242	CrCrCtD
Emtricitabine—Decitabine—Entecavir—hepatitis B	0.0307	0.175	CrCrCtD
Emtricitabine—Decitabine—Telbivudine—hepatitis B	0.0255	0.145	CrCrCtD
Emtricitabine—Decitabine—Lamivudine—hepatitis B	0.0233	0.133	CrCrCtD
Emtricitabine—Infection mixed—Entecavir—hepatitis B	0.00274	0.0638	CcSEcCtD
Emtricitabine—Fanconi syndrome—Adefovir Dipivoxil—hepatitis B	0.00268	0.0622	CcSEcCtD
Emtricitabine—Renal tubular disorder—Adefovir Dipivoxil—hepatitis B	0.00174	0.0404	CcSEcCtD
Emtricitabine—Osteomalacia—Adefovir Dipivoxil—hepatitis B	0.00146	0.0338	CcSEcCtD
Emtricitabine—Hepatitis B—Entecavir—hepatitis B	0.00142	0.0329	CcSEcCtD
Emtricitabine—Hepatitis B—Telbivudine—hepatitis B	0.00116	0.027	CcSEcCtD
Emtricitabine—Lactic acidosis—Entecavir—hepatitis B	0.00106	0.0246	CcSEcCtD
Emtricitabine—Depressive disorder—Lamivudine—hepatitis B	0.000885	0.0206	CcSEcCtD
Emtricitabine—Lactic acidosis—Telbivudine—hepatitis B	0.000871	0.0202	CcSEcCtD
Emtricitabine—Insulin resistance—Lamivudine—hepatitis B	0.000774	0.018	CcSEcCtD
Emtricitabine—Dysthymic disorder—Lamivudine—hepatitis B	0.000774	0.018	CcSEcCtD
Emtricitabine—Lipase increased—Telbivudine—hepatitis B	0.000723	0.0168	CcSEcCtD
Emtricitabine—Hepatitis B—Lamivudine—hepatitis B	0.000656	0.0152	CcSEcCtD
Emtricitabine—Lipodystrophy—Lamivudine—hepatitis B	0.000656	0.0152	CcSEcCtD
Emtricitabine—Buffalo hump—Lamivudine—hepatitis B	0.000597	0.0139	CcSEcCtD
Emtricitabine—Lipodystrophy acquired—Lamivudine—hepatitis B	0.000572	0.0133	CcSEcCtD
Emtricitabine—Basedow's disease—Lamivudine—hepatitis B	0.000549	0.0127	CcSEcCtD
Emtricitabine—Lipohypertrophy—Lamivudine—hepatitis B	0.000549	0.0127	CcSEcCtD
Emtricitabine—Hyperlactacidaemia—Lamivudine—hepatitis B	0.000528	0.0123	CcSEcCtD
Emtricitabine—Hypertrophy of breast—Lamivudine—hepatitis B	0.000508	0.0118	CcSEcCtD
Emtricitabine—Lactic acidosis—Lamivudine—hepatitis B	0.000491	0.0114	CcSEcCtD
Emtricitabine—Amylase increased—Telbivudine—hepatitis B	0.000446	0.0104	CcSEcCtD
Emtricitabine—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.000434	0.0101	CcSEcCtD
Emtricitabine—Fracture—Adefovir Dipivoxil—hepatitis B	0.000434	0.0101	CcSEcCtD
Emtricitabine—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.000434	0.0101	CcSEcCtD
Emtricitabine—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.000404	0.00939	CcSEcCtD
Emtricitabine—Hepatic steatosis—Lamivudine—hepatitis B	0.000397	0.00921	CcSEcCtD
Emtricitabine—Hepatomegaly—Entecavir—hepatitis B	0.000366	0.00849	CcSEcCtD
Emtricitabine—Myopathy—Adefovir Dipivoxil—hepatitis B	0.00036	0.00836	CcSEcCtD
Emtricitabine—Autoimmune disorder—Lamivudine—hepatitis B	0.000359	0.00834	CcSEcCtD
Emtricitabine—Glycosuria—Entecavir—hepatitis B	0.000319	0.00742	CcSEcCtD
Emtricitabine—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.000312	0.00724	CcSEcCtD
Emtricitabine—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.000309	0.00717	CcSEcCtD
Emtricitabine—Myopathy—Telbivudine—hepatitis B	0.000303	0.00704	CcSEcCtD
Emtricitabine—Hepatomegaly—Telbivudine—hepatitis B	0.0003	0.00698	CcSEcCtD
Emtricitabine—Opportunistic infection—Lamivudine—hepatitis B	0.000297	0.00691	CcSEcCtD
Emtricitabine—Cough increased—Adefovir Dipivoxil—hepatitis B	0.000276	0.00641	CcSEcCtD
Emtricitabine—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000265	0.00616	CcSEcCtD
Emtricitabine—Bone pain—Adefovir Dipivoxil—hepatitis B	0.000264	0.00612	CcSEcCtD
Emtricitabine—Amylase increased—Lamivudine—hepatitis B	0.000252	0.00584	CcSEcCtD
Emtricitabine—Rhabdomyolysis—Telbivudine—hepatitis B	0.00024	0.00558	CcSEcCtD
Emtricitabine—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.000228	0.00529	CcSEcCtD
Emtricitabine—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.000209	0.00484	CcSEcCtD
Emtricitabine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.000193	0.00447	CcSEcCtD
Emtricitabine—Breast enlargement—Lamivudine—hepatitis B	0.000185	0.00429	CcSEcCtD
Emtricitabine—Blood triglycerides increased—Lamivudine—hepatitis B	0.000183	0.00425	CcSEcCtD
Emtricitabine—Blood creatinine increased—Entecavir—hepatitis B	0.000176	0.00409	CcSEcCtD
Emtricitabine—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.000174	0.00404	CcSEcCtD
Emtricitabine—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.000172	0.00399	CcSEcCtD
Emtricitabine—Myopathy—Lamivudine—hepatitis B	0.000171	0.00397	CcSEcCtD
Emtricitabine—Hepatomegaly—Lamivudine—hepatitis B	0.000169	0.00393	CcSEcCtD
Emtricitabine—Renal impairment—Telbivudine—hepatitis B	0.000162	0.00377	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.000162	0.00375	CcSEcCtD
Emtricitabine—Pancreatitis—Entecavir—hepatitis B	0.000159	0.0037	CcSEcCtD
Emtricitabine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.000155	0.00361	CcSEcCtD
Emtricitabine—Neutropenia—Entecavir—hepatitis B	0.000152	0.00353	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Entecavir—hepatitis B	0.000151	0.0035	CcSEcCtD
Emtricitabine—Hyperglycaemia—Entecavir—hepatitis B	0.000146	0.0034	CcSEcCtD
Emtricitabine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.000143	0.00333	CcSEcCtD
Emtricitabine—Renal failure—Entecavir—hepatitis B	0.000142	0.0033	CcSEcCtD
Emtricitabine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.000139	0.00322	CcSEcCtD
Emtricitabine—Haematuria—Entecavir—hepatitis B	0.000138	0.00321	CcSEcCtD
Emtricitabine—Nasopharyngitis—Telbivudine—hepatitis B	0.000138	0.0032	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Entecavir—hepatitis B	0.000137	0.00318	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.000136	0.00316	CcSEcCtD
Emtricitabine—Muscular weakness—Telbivudine—hepatitis B	0.000136	0.00316	CcSEcCtD
Emtricitabine—Rhabdomyolysis—Lamivudine—hepatitis B	0.000135	0.00314	CcSEcCtD
Emtricitabine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.000135	0.00313	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.000134	0.0031	CcSEcCtD
Emtricitabine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.000132	0.00308	CcSEcCtD
Emtricitabine—Hepatitis—Entecavir—hepatitis B	0.00013	0.00302	CcSEcCtD
Emtricitabine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000127	0.00294	CcSEcCtD
Emtricitabine—Hypercholesterolaemia—Lamivudine—hepatitis B	0.000127	0.00294	CcSEcCtD
Emtricitabine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000126	0.00292	CcSEcCtD
Emtricitabine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000125	0.00291	CcSEcCtD
Emtricitabine—Neutropenia—Telbivudine—hepatitis B	0.000125	0.0029	CcSEcCtD
Emtricitabine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000125	0.00289	CcSEcCtD
Emtricitabine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.000124	0.00289	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.000124	0.00288	CcSEcCtD
Emtricitabine—Inflammation—Lamivudine—hepatitis B	0.000123	0.00287	CcSEcCtD
Emtricitabine—Immune system disorder—Entecavir—hepatitis B	0.000117	0.00273	CcSEcCtD
Emtricitabine—Renal failure—Telbivudine—hepatitis B	0.000117	0.00272	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Telbivudine—hepatitis B	0.000117	0.00271	CcSEcCtD
Emtricitabine—Mental disorder—Entecavir—hepatitis B	0.000114	0.00264	CcSEcCtD
Emtricitabine—Malnutrition—Entecavir—hepatitis B	0.000113	0.00263	CcSEcCtD
Emtricitabine—Neuropathy—Lamivudine—hepatitis B	0.000112	0.00261	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Telbivudine—hepatitis B	0.000112	0.00261	CcSEcCtD
Emtricitabine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00011	0.00256	CcSEcCtD
Emtricitabine—Urine output increased—Lamivudine—hepatitis B	0.000108	0.00252	CcSEcCtD
Emtricitabine—Back pain—Adefovir Dipivoxil—hepatitis B	0.000107	0.00248	CcSEcCtD
Emtricitabine—Hepatitis—Telbivudine—hepatitis B	0.000107	0.00248	CcSEcCtD
Emtricitabine—Pharyngitis—Telbivudine—hepatitis B	0.000106	0.00246	CcSEcCtD
Emtricitabine—Connective tissue disorder—Telbivudine—hepatitis B	0.000105	0.00244	CcSEcCtD
Emtricitabine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000102	0.00237	CcSEcCtD
Emtricitabine—Polyuria—Lamivudine—hepatitis B	9.9e-05	0.0023	CcSEcCtD
Emtricitabine—Gastroenteritis—Lamivudine—hepatitis B	9.81e-05	0.00228	CcSEcCtD
Emtricitabine—Cough—Adefovir Dipivoxil—hepatitis B	9.63e-05	0.00224	CcSEcCtD
Emtricitabine—Mediastinal disorder—Telbivudine—hepatitis B	9.62e-05	0.00223	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	9.56e-05	0.00222	CcSEcCtD
Emtricitabine—Myalgia—Adefovir Dipivoxil—hepatitis B	9.4e-05	0.00218	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	9.33e-05	0.00217	CcSEcCtD
Emtricitabine—Malnutrition—Telbivudine—hepatitis B	9.29e-05	0.00216	CcSEcCtD
Emtricitabine—Infection—Entecavir—hepatitis B	9.17e-05	0.00213	CcSEcCtD
Emtricitabine—Renal impairment—Lamivudine—hepatitis B	9.14e-05	0.00212	CcSEcCtD
Emtricitabine—Nervous system disorder—Entecavir—hepatitis B	9.05e-05	0.0021	CcSEcCtD
Emtricitabine—Back pain—Telbivudine—hepatitis B	8.99e-05	0.00209	CcSEcCtD
Emtricitabine—Skin disorder—Entecavir—hepatitis B	8.97e-05	0.00208	CcSEcCtD
Emtricitabine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	8.83e-05	0.00205	CcSEcCtD
Emtricitabine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	8.82e-05	0.00205	CcSEcCtD
Emtricitabine—Skin disorder—Adefovir Dipivoxil—hepatitis B	8.75e-05	0.00203	CcSEcCtD
Emtricitabine—Insomnia—Entecavir—hepatitis B	8.35e-05	0.00194	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	8.21e-05	0.00191	CcSEcCtD
Emtricitabine—Dyspepsia—Entecavir—hepatitis B	8.13e-05	0.00189	CcSEcCtD
Emtricitabine—Cough—Telbivudine—hepatitis B	8.11e-05	0.00188	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Entecavir—hepatitis B	7.97e-05	0.00185	CcSEcCtD
Emtricitabine—Fatigue—Entecavir—hepatitis B	7.96e-05	0.00185	CcSEcCtD
Emtricitabine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	7.93e-05	0.00184	CcSEcCtD
Emtricitabine—Myalgia—Telbivudine—hepatitis B	7.91e-05	0.00184	CcSEcCtD
Emtricitabine—Arthralgia—Telbivudine—hepatitis B	7.91e-05	0.00184	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	7.86e-05	0.00182	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	7.78e-05	0.00181	CcSEcCtD
Emtricitabine—Nasopharyngitis—Lamivudine—hepatitis B	7.78e-05	0.00181	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Lamivudine—hepatitis B	7.67e-05	0.00178	CcSEcCtD
Emtricitabine—Muscular weakness—Lamivudine—hepatitis B	7.67e-05	0.00178	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Entecavir—hepatitis B	7.55e-05	0.00175	CcSEcCtD
Emtricitabine—Nervous system disorder—Telbivudine—hepatitis B	7.44e-05	0.00173	CcSEcCtD
Emtricitabine—Thrombocytopenia—Telbivudine—hepatitis B	7.42e-05	0.00172	CcSEcCtD
Emtricitabine—Pancreatitis—Lamivudine—hepatitis B	7.37e-05	0.00171	CcSEcCtD
Emtricitabine—Skin disorder—Telbivudine—hepatitis B	7.37e-05	0.00171	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	7.36e-05	0.00171	CcSEcCtD
Emtricitabine—Body temperature increased—Entecavir—hepatitis B	7.3e-05	0.0017	CcSEcCtD
Emtricitabine—Abdominal pain—Entecavir—hepatitis B	7.3e-05	0.0017	CcSEcCtD
Emtricitabine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	7.12e-05	0.00165	CcSEcCtD
Emtricitabine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	7.12e-05	0.00165	CcSEcCtD
Emtricitabine—Neutropenia—Lamivudine—hepatitis B	7.03e-05	0.00163	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Telbivudine—hepatitis B	6.91e-05	0.0016	CcSEcCtD
Emtricitabine—Insomnia—Telbivudine—hepatitis B	6.86e-05	0.00159	CcSEcCtD
Emtricitabine—Paraesthesia—Telbivudine—hepatitis B	6.81e-05	0.00158	CcSEcCtD
Emtricitabine—Hyperglycaemia—Lamivudine—hepatitis B	6.78e-05	0.00157	CcSEcCtD
Emtricitabine—Depression—Lamivudine—hepatitis B	6.68e-05	0.00155	CcSEcCtD
Emtricitabine—Dyspepsia—Telbivudine—hepatitis B	6.68e-05	0.00155	CcSEcCtD
Emtricitabine—Asthenia—Entecavir—hepatitis B	6.62e-05	0.00154	CcSEcCtD
Emtricitabine—Renal failure—Lamivudine—hepatitis B	6.59e-05	0.00153	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Lamivudine—hepatitis B	6.57e-05	0.00153	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Telbivudine—hepatitis B	6.55e-05	0.00152	CcSEcCtD
Emtricitabine—Fatigue—Telbivudine—hepatitis B	6.54e-05	0.00152	CcSEcCtD
Emtricitabine—Pain—Telbivudine—hepatitis B	6.48e-05	0.00151	CcSEcCtD
Emtricitabine—Asthenia—Adefovir Dipivoxil—hepatitis B	6.46e-05	0.0015	CcSEcCtD
Emtricitabine—Pruritus—Adefovir Dipivoxil—hepatitis B	6.37e-05	0.00148	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Lamivudine—hepatitis B	6.34e-05	0.00147	CcSEcCtD
Emtricitabine—Diarrhoea—Entecavir—hepatitis B	6.32e-05	0.00147	CcSEcCtD
Emtricitabine—Sinusitis—Lamivudine—hepatitis B	6.29e-05	0.00146	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Telbivudine—hepatitis B	6.2e-05	0.00144	CcSEcCtD
Emtricitabine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	6.16e-05	0.00143	CcSEcCtD
Emtricitabine—Dizziness—Entecavir—hepatitis B	6.1e-05	0.00142	CcSEcCtD
Emtricitabine—Rhinitis—Lamivudine—hepatitis B	6.03e-05	0.0014	CcSEcCtD
Emtricitabine—Hepatitis—Lamivudine—hepatitis B	6.02e-05	0.0014	CcSEcCtD
Emtricitabine—Body temperature increased—Telbivudine—hepatitis B	5.99e-05	0.00139	CcSEcCtD
Emtricitabine—Abdominal pain—Telbivudine—hepatitis B	5.99e-05	0.00139	CcSEcCtD
Emtricitabine—Pharyngitis—Lamivudine—hepatitis B	5.97e-05	0.00139	CcSEcCtD
Emtricitabine—Connective tissue disorder—Lamivudine—hepatitis B	5.91e-05	0.00137	CcSEcCtD
Emtricitabine—Vomiting—Entecavir—hepatitis B	5.87e-05	0.00136	CcSEcCtD
Emtricitabine—Rash—Entecavir—hepatitis B	5.82e-05	0.00135	CcSEcCtD
Emtricitabine—Dermatitis—Entecavir—hepatitis B	5.82e-05	0.00135	CcSEcCtD
Emtricitabine—Headache—Entecavir—hepatitis B	5.78e-05	0.00134	CcSEcCtD
Emtricitabine—Vomiting—Adefovir Dipivoxil—hepatitis B	5.73e-05	0.00133	CcSEcCtD
Emtricitabine—Rash—Adefovir Dipivoxil—hepatitis B	5.68e-05	0.00132	CcSEcCtD
Emtricitabine—Dermatitis—Adefovir Dipivoxil—hepatitis B	5.67e-05	0.00132	CcSEcCtD
Emtricitabine—Headache—Adefovir Dipivoxil—hepatitis B	5.64e-05	0.00131	CcSEcCtD
Emtricitabine—Nausea—Entecavir—hepatitis B	5.48e-05	0.00127	CcSEcCtD
Emtricitabine—Asthenia—Telbivudine—hepatitis B	5.44e-05	0.00126	CcSEcCtD
Emtricitabine—Immune system disorder—Lamivudine—hepatitis B	5.43e-05	0.00126	CcSEcCtD
Emtricitabine—Mediastinal disorder—Lamivudine—hepatitis B	5.42e-05	0.00126	CcSEcCtD
Emtricitabine—Pruritus—Telbivudine—hepatitis B	5.37e-05	0.00125	CcSEcCtD
Emtricitabine—Nausea—Adefovir Dipivoxil—hepatitis B	5.35e-05	0.00124	CcSEcCtD
Emtricitabine—Malnutrition—Lamivudine—hepatitis B	5.24e-05	0.00122	CcSEcCtD
Emtricitabine—Diarrhoea—Telbivudine—hepatitis B	5.19e-05	0.00121	CcSEcCtD
Emtricitabine—Back pain—Lamivudine—hepatitis B	5.07e-05	0.00118	CcSEcCtD
Emtricitabine—Dizziness—Telbivudine—hepatitis B	5.01e-05	0.00116	CcSEcCtD
Emtricitabine—Anaemia—Lamivudine—hepatitis B	4.84e-05	0.00112	CcSEcCtD
Emtricitabine—Vomiting—Telbivudine—hepatitis B	4.82e-05	0.00112	CcSEcCtD
Emtricitabine—Angioedema—Lamivudine—hepatitis B	4.78e-05	0.00111	CcSEcCtD
Emtricitabine—Rash—Telbivudine—hepatitis B	4.78e-05	0.00111	CcSEcCtD
Emtricitabine—Dermatitis—Telbivudine—hepatitis B	4.78e-05	0.00111	CcSEcCtD
Emtricitabine—Headache—Telbivudine—hepatitis B	4.75e-05	0.0011	CcSEcCtD
Emtricitabine—Cough—Lamivudine—hepatitis B	4.57e-05	0.00106	CcSEcCtD
Emtricitabine—Nausea—Telbivudine—hepatitis B	4.5e-05	0.00105	CcSEcCtD
Emtricitabine—Myalgia—Lamivudine—hepatitis B	4.46e-05	0.00104	CcSEcCtD
Emtricitabine—Arthralgia—Lamivudine—hepatitis B	4.46e-05	0.00104	CcSEcCtD
Emtricitabine—Anxiety—Lamivudine—hepatitis B	4.44e-05	0.00103	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	4.43e-05	0.00103	CcSEcCtD
Emtricitabine—Infection—Lamivudine—hepatitis B	4.25e-05	0.000986	CcSEcCtD
Emtricitabine—Nervous system disorder—Lamivudine—hepatitis B	4.19e-05	0.000974	CcSEcCtD
Emtricitabine—Thrombocytopenia—Lamivudine—hepatitis B	4.18e-05	0.000972	CcSEcCtD
Emtricitabine—Skin disorder—Lamivudine—hepatitis B	4.15e-05	0.000964	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Lamivudine—hepatitis B	3.89e-05	0.000904	CcSEcCtD
Emtricitabine—Insomnia—Lamivudine—hepatitis B	3.87e-05	0.000898	CcSEcCtD
Emtricitabine—Paraesthesia—Lamivudine—hepatitis B	3.84e-05	0.000891	CcSEcCtD
Emtricitabine—Dyspnoea—Lamivudine—hepatitis B	3.81e-05	0.000885	CcSEcCtD
Emtricitabine—Dyspepsia—Lamivudine—hepatitis B	3.76e-05	0.000874	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Lamivudine—hepatitis B	3.69e-05	0.000857	CcSEcCtD
Emtricitabine—Fatigue—Lamivudine—hepatitis B	3.68e-05	0.000856	CcSEcCtD
Emtricitabine—Pain—Lamivudine—hepatitis B	3.65e-05	0.000849	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Lamivudine—hepatitis B	3.49e-05	0.000812	CcSEcCtD
Emtricitabine—Urticaria—Lamivudine—hepatitis B	3.4e-05	0.000789	CcSEcCtD
Emtricitabine—Abdominal pain—Lamivudine—hepatitis B	3.38e-05	0.000785	CcSEcCtD
Emtricitabine—Body temperature increased—Lamivudine—hepatitis B	3.38e-05	0.000785	CcSEcCtD
Emtricitabine—Hypersensitivity—Lamivudine—hepatitis B	3.15e-05	0.000731	CcSEcCtD
Emtricitabine—Asthenia—Lamivudine—hepatitis B	3.07e-05	0.000712	CcSEcCtD
Emtricitabine—Pruritus—Lamivudine—hepatitis B	3.02e-05	0.000702	CcSEcCtD
Emtricitabine—Diarrhoea—Lamivudine—hepatitis B	2.92e-05	0.000679	CcSEcCtD
Emtricitabine—Dizziness—Lamivudine—hepatitis B	2.83e-05	0.000656	CcSEcCtD
Emtricitabine—Vomiting—Lamivudine—hepatitis B	2.72e-05	0.000631	CcSEcCtD
Emtricitabine—Rash—Lamivudine—hepatitis B	2.69e-05	0.000626	CcSEcCtD
Emtricitabine—Dermatitis—Lamivudine—hepatitis B	2.69e-05	0.000625	CcSEcCtD
Emtricitabine—Headache—Lamivudine—hepatitis B	2.68e-05	0.000622	CcSEcCtD
Emtricitabine—Nausea—Lamivudine—hepatitis B	2.54e-05	0.00059	CcSEcCtD
